Onda H, Goldhamer D J, Tassava R A
Department of Molecular Genetics, Ohio State University, Columbus 43210.
Development. 1990 Apr;108(4):657-68. doi: 10.1242/dev.108.4.657.
Several well-characterized extracellular matrix (ECM) components have been localized to the amphibian limb regenerate, but the identification and characterization of novel ECM molecules have received little attention. Here we describe, using mAb MT1 and immunocytochemistry, an ECM molecule expressed during limb regeneration and limb development. In limb stumps, mAb MT1 reactivity was restricted to tendons, myotendinous junctions, granules in the basal layers of epidermis, periosteum (newts) and perichondrium (axolotls). In regenerating limbs, reactivity in the distal limb stump was first detected 5 days and 1 day after amputation of newt and axolotl limbs, respectively. In both species, mAb MT1 recognized what appeared to be an abundant blastema matrix antigen, localized in both thin and thick cords between and sometimes closely associated with blastema cells. Reactivity was generally uniform throughout the blastema except for a particularly thick layer that was present immediately beneath the wound epithelium. During redifferentiation stages, mAb MT1 reactivity persisted among blastema cells and redifferentiating cartilage but was lost proximally in areas of muscle and connective tissue differentiation. During the entire period of embryonic limb development, mAb MT1 reactivity was seen in the ECM of the mesenchyme and in a layer beneath the limb bud ectoderm, similar to its distribution during regeneration. Considerable mAb MT1 reactivity was also associated with the developing somites. The reactivity of mAb MT1 in blastema and limb bud was similar if not identical to that of a polyclonal Ab against tenascin (pAbTN), a large, extracellular matrix glycoprotein implicated in growth control, inductive interactions, and other developmental events. This pAbTN effectively competed against mAb MT1 binding on blastema sections. In immunoblots, both mAb MT1 and pAbTN recognized a very high molecular weight (approximately Mr 1000 x 10(3)) protein in blastema extracts of both newts and axolotls. mAb MT1 immunoprecipitated a protein of Mr 1000K size which reacted to both mAb MT1 and pAbTN in immunoblots. These data show that tenascin is in the matrix of the urodele blastema and limb bud, and suggest that mAb MT1 identifies urodele tenascin.
几种特征明确的细胞外基质(ECM)成分已定位到两栖动物肢体再生部位,但新型ECM分子的鉴定和表征却很少受到关注。在此,我们使用单克隆抗体MT1和免疫细胞化学方法,描述了一种在肢体再生和肢体发育过程中表达的ECM分子。在肢体残端,单克隆抗体MT1的反应性局限于肌腱、肌腱连接、表皮基底层的颗粒、骨膜(蝾螈)和软骨膜(美西螈)。在再生肢体中,分别在蝾螈和美西螈肢体截肢后5天和1天首次在远端肢体残端检测到反应性。在这两个物种中,单克隆抗体MT1识别出一种似乎是丰富的芽基基质抗原,定位于芽基细胞之间的细索和粗索中,有时与芽基细胞紧密相关。除了伤口上皮下方紧邻的一层特别厚的区域外,整个芽基中的反应性通常是均匀的。在再分化阶段,单克隆抗体MT1的反应性在芽基细胞和再分化软骨中持续存在,但在肌肉和结缔组织分化区域近端消失。在胚胎肢体发育的整个时期,在间充质的ECM和肢体芽外胚层下方的一层中都可见到单克隆抗体MT1的反应性,类似于其在再生过程中的分布。相当多的单克隆抗体MT1反应性也与发育中的体节相关。单克隆抗体MT1在芽基和肢体芽中的反应性与抗腱生蛋白的多克隆抗体(pAbTN)相似,如果不是完全相同的话,腱生蛋白是一种参与生长控制、诱导相互作用和其他发育事件的大型细胞外基质糖蛋白。这种pAbTN有效地竞争了单克隆抗体MT1在芽基切片上的结合。在免疫印迹中,单克隆抗体MT1和pAbTN都在蝾螈和美西螈芽基提取物中识别出一种非常高分子量(约Mr 1000×10³)的蛋白质。单克隆抗体MT1免疫沉淀出一种Mr 1000K大小的蛋白质,该蛋白质在免疫印迹中与单克隆抗体MT1和pAbTN都发生反应。这些数据表明腱生蛋白存在于有尾目动物芽基和肢体芽的基质中,并表明单克隆抗体MT1识别有尾目动物的腱生蛋白。